BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24465937)

  • 21. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ureteral pseudodiverticulosis and urothelial cell carcinoma: rethinking the association.
    Morgan MA; Chua WY; Zafar HM; Papanicolaou N; Ramchandani P
    Abdom Radiol (NY); 2019 Jan; 44(1):234-238. PubMed ID: 30078084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome instability and progression in urothelial cell carcinoma of the bladder.
    Santos L; Pereira S; Leite RP; Souto M; Amaro T; Criado B
    Acta Oncol; 2003; 42(2):169-73. PubMed ID: 12801136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relation between Ring Box-1 protein overexpression and tumor grade and stage in bladder urothelial cell carcinoma.
    Celik ZE; Kaynar M; Karabagli P; Gergerlioglu N; Goktas S
    Cancer Biomark; 2017 Dec; 20(4):389-394. PubMed ID: 28946546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer.
    Marín-Aguilera M; Mengual L; Ribal MJ; Ars E; Ríos J; Gázquez C; Villavicencio H; Alcaraz A
    Urology; 2012 Jan; 79(1):240.e9-15. PubMed ID: 22055693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
    Vlajnic T; Gut A; Savic S; Bubendorf L
    J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine.
    Maldonado L; Brait M; Michailidi C; Munari E; Driscoll T; Schultz L; Bivalacqua T; Schoenberg M; Sidransky D; Netto GJ; Hoque MO
    Oncotarget; 2014 Jul; 5(14):5218-33. PubMed ID: 24980822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation.
    Zhang L; Xiong G; Fang D; Li X; Liu J; Ci W; Zhao W; Singla N; He Z; Zhou L
    J Exp Clin Cancer Res; 2015 Jan; 34(1):5. PubMed ID: 25613404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features.
    Yu YL; Su KJ; Hsieh MJ; Wang SS; Wang PH; Weng WC; Yang SF
    PLoS One; 2014; 9(4):e93635. PubMed ID: 24691023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation of genetic and cytogenetic alterations in pathological aggressiveness urothelial carcinoma of the bladder: Performance of BCA-1, a mini-array comparative genomic hybridisation-based test].
    Léon P; Cancel Tassin G; Sighar K; Compérat E; Gaffory C; Ondet V; Hugonin S; Audouin M; Doizi S; Traxer O; Ciofu C; Rouprêt M; Lacave R; Cussenot O
    Prog Urol; 2017; 27(8-9):451-457. PubMed ID: 28576425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study.
    Dugué PA; Brinkman MT; Milne RL; Wong EM; FitzGerald LM; Bassett JK; Joo JE; Jung CH; Makalic E; Schmidt DF; Park DJ; Chung J; Ta AD; Bolton DM; Lonie A; Longano A; Hopper JL; Severi G; Saffery R; English DR; Southey MC; Giles GG
    Br J Cancer; 2016 Sep; 115(6):664-73. PubMed ID: 27490804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of VEGF-C genetic polymorphisms with urothelial cell carcinoma susceptibility differ between smokers and non-smokers in Taiwan.
    Tung MC; Hsieh MJ; Wang SS; Yang SF; Chen SS; Wang SW; Lee LM; Lee WJ; Chien MH
    PLoS One; 2014; 9(3):e91147. PubMed ID: 24608123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic, staging, and grading of urothelial carcinomas from urine: performance of BCA-1, a mini-array comparative genomic hybridisation-based test.
    Larré S; Camparo P; Comperat E; Gil Diez De Medina S; Traxer O; Roupret M; Sebe P; Cancel-Tassin G; Sighar K; Lozach F; Cussenot O
    Eur Urol; 2011 Feb; 59(2):250-7. PubMed ID: 21056532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infrequent microsatellite instability in urothelial cell carcinoma of the bladder in young patients.
    Mongiat-Artus P; Miquel C; van der Aa M; Buhard O; Hamelin R; Bangma C; Teillac P; van der Kwast T; Praz F
    Eur Urol; 2006 Apr; 49(4):685-90. PubMed ID: 16413104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
    Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
    Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia.
    Ohyashiki K; Yahata N; Ohyashiki JH; Iwama H; Hayashi S; Ando K; Aizawa T; Ito T; Miki M; Ebihara Y
    Cancer; 1998 Dec; 83(12):2554-60. PubMed ID: 9874463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine.
    van Rhijn BW; Lurkin I; Chopin DK; Kirkels WJ; Thiery JP; van der Kwast TH; Radvanyi F; Zwarthoff EC
    Clin Cancer Res; 2003 Jan; 9(1):257-63. PubMed ID: 12538478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Consumption of Green Tea Suppresses Urinary Tract Recurrence of Urothelial Cancer
    Yasuda T; Miyata Y; Nakamura Y; Sagara Y; Matsuo T; Ohba K; Sakai H
    In Vivo; 2018; 32(4):721-729. PubMed ID: 29936451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.